Spruce Biosciences, Inc. Earnings Per Share, Basic and Diluted
Spruce Biosciences, Inc. (SPRB) reported Earnings Per Share, Basic and Diluted of -$0.51 per share for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-08-10.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-08-10
- Spruce Biosciences, Inc. earnings per share, basic and diluted for the quarter ending 2022-06-30 was -$0.51.
- Spruce Biosciences, Inc. earnings per share, basic and diluted for the quarter ending 2022-03-31 was -$0.50.
- Spruce Biosciences, Inc. earnings per share, basic and diluted for the quarter ending 2021-12-31 was -$0.39.
- Spruce Biosciences, Inc. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.49.
- Spruce Biosciences, Inc. earnings per share, basic and diluted for fiscal 2021 was -$1.81.
- Spruce Biosciences, Inc. earnings per share, basic and diluted for fiscal 2020 was -$4.93.
- Spruce Biosciences, Inc. earnings per share, basic and diluted for fiscal 2019 was -$17.12.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2022-06-30 | -$0.51 10-Q · filed 2022-08-10 | -$1.01 10-Q · filed 2022-08-10 | -$1.40 derived: net income ÷ weighted average shares · filed 2023-08-14 | -$1.89 derived: net income ÷ weighted average shares · filed 2023-08-14 |
| 2022-03-31 | -$0.50 10-Q · filed 2022-05-11 | -$0.89 derived: net income ÷ weighted average shares · filed 2023-05-15 | -$1.38 derived: net income ÷ weighted average shares · filed 2023-05-15 | -$1.89 derived: net income ÷ weighted average shares · filed 2023-05-15 |
| 2021-12-31 | -$0.39 derived: net income ÷ weighted average shares · filed 2023-03-16 | -$0.88 derived: net income ÷ weighted average shares · filed 2023-03-16 | -$1.39 derived: net income ÷ weighted average shares · filed 2023-03-16 | -$1.81 10-K · filed 2022-03-14 |
| 2021-09-30 | -$0.49 10-Q · filed 2021-11-15 | -$0.99 derived: net income ÷ weighted average shares · filed 2022-11-10 | -$1.42 10-Q · filed 2021-11-15 | -$1.81 derived: net income ÷ weighted average shares · filed 2022-11-10 |
| 2021-06-30 | -$0.50 10-Q · filed 2022-08-10 | -$0.93 10-Q · filed 2022-08-10 | -$1.32 derived: net income ÷ weighted average shares · filed 2022-08-10 | -$2.29 derived: net income ÷ weighted average shares · filed 2022-08-10 |
| 2021-03-31 | -$0.42 10-Q · filed 2022-05-11 | -$0.81 derived: net income ÷ weighted average shares · filed 2022-05-11 | -$1.83 derived: net income ÷ weighted average shares · filed 2022-05-11 | -$2.95 derived: net income ÷ weighted average shares · filed 2022-05-11 |
| 2020-12-31 | -$0.39 derived: net income ÷ weighted average shares · filed 2022-03-14 | -$1.60 derived: net income ÷ weighted average shares · filed 2022-03-14 | -$3.15 derived: net income ÷ weighted average shares · filed 2022-03-14 | -$4.93 10-K · filed 2022-03-14 |
| 2020-09-30 | -$12.35 10-Q · filed 2021-11-15 | -$20.81 derived: net income ÷ weighted average shares · filed 2021-11-15 | -$27.54 10-Q · filed 2021-11-15 | -$31.78 derived: net income ÷ weighted average shares · filed 2021-11-15 |
| 2020-06-30 | -$8.43 10-Q · filed 2021-08-10 | -$15.15 10-Q · filed 2021-08-10 | -$19.36 derived: net income ÷ weighted average shares · filed 2021-08-10 | -$22.69 derived: net income ÷ weighted average shares · filed 2021-08-10 |
| 2020-03-31 | -$6.76 10-Q · filed 2021-05-12 | -$10.92 derived: net income ÷ weighted average shares · filed 2021-05-12 | -$14.26 derived: net income ÷ weighted average shares · filed 2021-05-12 | |
| 2019-12-31 | -$4.16 derived: net income ÷ weighted average shares · filed 2021-03-22 | -$7.50 derived: net income ÷ weighted average shares · filed 2021-03-22 | -$17.12 10-K · filed 2021-03-22 | |
| 2019-09-30 | -$3.34 10-Q · filed 2020-11-18 | -$12.96 10-Q · filed 2020-11-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |